A Golgi apparatus‑related subtype and risk signature predicts prognosis and evaluates immunotherapy response in gastric cancer
This study underscores the association between Golgi apparatus subtypes and GC immunotumor microenvironment. GARRS, validated for its prognostic, immune infiltration, and drug sensitivity predictive abilities, offers new insights into gastric cancer treatment strategies.
Authors
- Ruyue Chen (ORCID: https://orcid.org/0000-0002-0847-4740)
- Zengwu Yao
- Jinchen Hu (ORCID: https://orcid.org/0000-0002-2674-0782)
- Lixin Jiang
Institutions
- Qingdao University (CN)
- Yuhuangding Hospital (CN)
- Yantaishan Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1007/s12672-025-01827-6
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 2.09